Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Nature Cancer|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trialSolange Peters, Daniel S W Tan, David E Gerber, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.NPJ Vaccines|November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancerRajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.The Lancet. Oncology|October 30, 2020
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocolMary W Redman, Vassiliki A Papadimitrakopoulou, Katherine Minichiello, et al.Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.Carcinogenesis|February 14, 2014
HPV-associated lung cancers: an international pooled analysisCamille Ragin, Monisola Obikoya-Malomo, Sungjin Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.Pageof 7